Related Experiment Video
Updated: Jun 21, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Adenosine receptors and the central nervous system
Ana M Sebastião1, Joaquim A Ribeiro
1Institute of Pharmacology and Neurosciences, Institute of Molecular Medicine, University of Lisbon, 1649-028 Lisbon, Portugal. anaseb@fm.ul.pt
Adenosine receptors (ARs) regulate neurotransmitter release and synaptic transmission. Targeting these receptors offers potential therapeutic strategies for neurological and psychiatric diseases.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Adenosine receptors (ARs) are crucial regulators of neurotransmitter release and neuromodulator action in the nervous system.
- ARs, particularly A(2A)ARs and A(1)ARs, are widely distributed in neurons and glia, influencing synaptic transmission and plasticity.
- Adenosine's role as a 'maestro' of the tripartite synapse is highlighted, especially following brain insults.
Purpose of the Study:
- To explore the multifaceted roles of adenosine receptors in both physiological and pathological conditions of the brain.
- To investigate the therapeutic potential of targeting specific adenosine receptors for neurological and psychiatric disorders.
Main Methods:
- The study reviews the known functions and distribution of adenosine receptors (A(1)ARs and A(2A)ARs) in the central nervous system.
- It examines the involvement of ARs in various physiological processes like sleep, cognition, and memory.
- The abstract discusses the implications of ARs in pathological conditions such as Parkinson's, Alzheimer's, stroke, and depression.
Main Results:
- Both A(1)ARs and A(2A)ARs are vital for normal brain function, including sleep, cognition, and memory.
- Dysregulation of ARs is implicated in numerous neurological and psychiatric diseases.
- Therapeutic strategies targeting ARs show promise, with A(1)AR agonists and A(2A)AR antagonists demonstrating potential neuroprotective effects or disease modification depending on the condition and timing.
Conclusions:
- Adenosine receptors play a complex role in brain function and disease.
- Selective targeting of A(1)ARs and A(2A)ARs presents a promising avenue for novel therapeutic interventions in neurological and psychiatric disorders.
- Further research and clinical trials are essential to fully elucidate the therapeutic potential of AR modulation for patient benefit.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...

